Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Childs

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
BMC Genomics|March 23, 2010
Single feature polymorphism (SFP)-based selective sweep identification and association mapping of growth-related metabolic traits in Arabidopsis thalianaLiam H Childs, Hanna Witucka-Wall, Torsten Günther, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosisNam-Sihk Lee, Laura Barber, Ali Kanchwala, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 21, 2025
Exploratory biomarker analysis from a phase III study of the PI3K inhibitor, copanlisib, in combination with rituximab in patients with indolent non-Hodgkin lymphoma, a retrospective studyShalini Chaturvedi, Anke Weispfenning, Tine Descamps, et al.
Gut|March 1, 1983
Psychological stress and the passage of a standard meal through the stomach and small intestine in manP A Cann, N W Read, J Cammack, et al.
Clinical and Translational Science|April 12, 2023
Model-informed approach to support pediatric dosing for the pan-PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumorsPeter N Morcos, Jan Schlender, Rolf Burghaus, et al.
Obesity Surgery|June 11, 2008
Explanations for unsuccessful weight loss among bariatric surgery candidatesKevin O Hwang, Joseph H Childs, G Ken Goodrick, et al.
Breast Cancer Research and Treatment|November 21, 2013
Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancerDenise A Yardley, Lowell Hart, David Waterhouse, et al.
Springerplus|May 27, 2014
Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancerSara A Hurvitz, Linda D Bosserman, David Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePTH S Hochster, A Grothey, L Hart, et al.
The New England Journal of Medicine|April 28, 1994
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantationE B Papadopoulos, M Ladanyi, D Emanuel, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
BMC Genomics|March 23, 2010
Single feature polymorphism (SFP)-based selective sweep identification and association mapping of growth-related metabolic traits in Arabidopsis thalianaLiam H Childs, Hanna Witucka-Wall, Torsten Günther, et al.
Clinical and Vaccine Immunology : CVI|December 24, 2010
Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosisNam-Sihk Lee, Laura Barber, Ali Kanchwala, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 21, 2025
Exploratory biomarker analysis from a phase III study of the PI3K inhibitor, copanlisib, in combination with rituximab in patients with indolent non-Hodgkin lymphoma, a retrospective studyShalini Chaturvedi, Anke Weispfenning, Tine Descamps, et al.
Gut|March 1, 1983
Psychological stress and the passage of a standard meal through the stomach and small intestine in manP A Cann, N W Read, J Cammack, et al.
Clinical and Translational Science|April 12, 2023
Model-informed approach to support pediatric dosing for the pan-PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumorsPeter N Morcos, Jan Schlender, Rolf Burghaus, et al.
Obesity Surgery|June 11, 2008
Explanations for unsuccessful weight loss among bariatric surgery candidatesKevin O Hwang, Joseph H Childs, G Ken Goodrick, et al.
Breast Cancer Research and Treatment|November 21, 2013
Addition of bevacizumab to three docetaxel regimens as adjuvant therapy for early stage breast cancerDenise A Yardley, Lowell Hart, David Waterhouse, et al.
Springerplus|May 27, 2014
Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancerSara A Hurvitz, Linda D Bosserman, David Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePTH S Hochster, A Grothey, L Hart, et al.
The New England Journal of Medicine|April 28, 1994
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantationE B Papadopoulos, M Ladanyi, D Emanuel, et al.
Pageof 9